Thank you @NatureNews for the mention of our CEO @borodehansen and bringing to light the challenges and great work of delivering RNA-interference therapeutics to their target cells #RNA #biotech #RareDisease #GeneTherapy #genetics

Thank you @OTSociety for a wonderful conference in Munich We were so pleased to announce our progress with @BioNTech_Group for the treatment of OTC at #otsmunich

We are so excited to announce that Bo Rode Hansen, MBA, PhD, President and Chief Executive Officer of Genevant Sciences, is scheduled to present at the Jefferies 2019 Healthcare Conference in New York City on Friday, June 7, 2019 at 8:00 am EDT.

We did it! Year 1 and many more. So proud of the work done by our 52 people strong across Cambridge and Vancouver building the future of RNA therapies. Congratulations everyone!

Genevant Sciences is pleased to announce that our President & CEO Bo Rode Hansen will be the closing speaker at the OPT Congress in Boston on Wed 3/27. Learn about the exciting future of nucleic acid delivery platforms with Genevant's Pan-RNA approach. #OPTBoston

Genevant Sciences is pleased to announce that our President & CEO Bo Rode Hansen will be the closing speaker at the OPT Congress in Boston on Wed, March 27th. Learn about the exciting accomplishments and future of nucleic acid delivery platforms with Genevant's Pan-RNA approach.

Excited to round out our leadership team and continue pushing our mission forward! #RNA #research #biotech #firsttweet